Sign In / Register         Shopping cart (0)

Recombinant Human ANGPT2 Protein(His tag) (HH0136AL)

Recombinant Human ANGPT2 Protein (O15123) (Met 1-Phe 496) with a polyhistidine tag at the C-terminus was expressed in HEK293.

Size Price Qty
20ug $319.00
Order Online          Bulk Inquiry

PRODUCT INFORMATION

Cat.No.
HH0136AL
Synonyms
ANGPT2; Ang2; ANG-2; ANG2; AGPT2;
Accession
Predicted N Terminal
Tyr 19
Form
Lyophilized from sterile PBS, pH 7.4, 5 % trehalose and 5 % mannitol.
Bio-activity
Measured by its ability to bind recombinant human Tie2-His in a functional ELISA. Measured by its ability to bind recombinant human Tie2-Fch in a functional ELISA.
Molecular Mass
Recombinant Human Ang2 consists of 489 amino acids and predicts a molecular mass of 56.3 kDa. As a result of glycosylation, the rhAng2 migRates as approximately 60-70 kDa band in SDS-PAGE under reducing conditions.
Endotoxin
< 1.0 EU per 1 microgram of protein (determined by LAL method).
Purity
> 92 % by SDS-PAGE.
Storage
In lyophilized state for 1 year (4°C); After reconstitution under sterile conditions for 3 months (-70°C). Avoid repeated freeze/thaw cycles.
Reconstitution
Reconstitute in sterile distilled water to a concentration of 0.1-1.0 mg/mL.
Warning
For research use only!
Background
Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth.
Tag
His
Species
Human
Source
HEK293

BACKGROUND

Background
Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth.
Online Inquiry

Fill out this form and one of our experts will respond to you within one business day.